16
ADVANCED DIGITAL DESIGN OF PHARMACEUTICAL THERAPEUTICS Modelling pharmaceutical crystallisation processes using a coupled CFD-population balance approach D. M. Camacho, C. Y. Ma, T. Mahmud and K. J. Roberts School of Chemical and Process Engineering, University of Leeds 27/07/2017 BACG 2017

Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

  • Upload
    vunhan

  • View
    227

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

ADVANCED DIGITAL DESIGN OF PHARMACEUTICAL THERAPEUTICS

Modelling pharmaceutical crystallisation processes using a coupled CFD-population balance approachD. M. C a macho, C . Y. Ma , T. Ma hmud a nd K . J . Roberts

Sc hool o f C hemica l a nd Process E ng ineer ing , U nivers i ty o f Leeds

27/07/2017 BACG 2017

Page 2: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

27/07/2017 BACG 2017

2

Particle Formation Via Crystallisation

Crystallisation is an essential process for the isolation & purification of APIs

Process is driven by supersaturation involving two keysteps, which affect the design of particles formed:nucleation & crystal growth

Nucleation

Particle size Polymorphic form

Crystalinity

Crystal shape

Product purity

Agglomerability

Growth

Controlling competing demands for supersaturation by nucleation & growth is key issue for both particle design & process scale up

Page 3: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

27/07/2017 BACG 2017

3

Modelling Approach Context

Common crystallisation models assume perfectly mixed volume

Incorrect estimation of nucleation, growth & agglomeration rates results in errors in predicted particle size & shape distributions

Stirred tanks are inhomogeneous fluid mechanical environment

Limited applicability of existing models in extrapolation to other scales of operations or other geometries

Available models still are input-output which are tuned for a single configuration

Robust process development & scale up requires detail knowledge of solid concentration distribution, supersaturation distribution, local velocities, shear rates, energy dissipation rates ….

Crystallisation generally performed in glass-lined jacketed stirred crystallisers with different configurations

To this issue add

Design of a crystalliser & selection of operating conditions are vital for obtaining crystals with the required physical properties. e.g. crystal size distribution (CSD), morphology & purity

Modelling approach coupling computational fluid dynamics (CFD) & population balance model (PBM)

Page 4: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Holistic Framework for Modelling Crystallisation Processes

4

27/07/2017 BACG 2017

Zonal Process

Model

gCRYSTAL

CFD Fluent

Hydrodynamics/

Mixing/Heat

Transfer

UDF

Network of Well-mixed Zones

Morphological Population Balance (MPBM)/Poster (30)

Fully Couple CFD -1D Population Balance (PBM)

Solubility, Nucleation & Growth Kinetics Models

Crystallisation Process Data for Model

Validation

0

2

4

6

8

10

0.1 1 10 100 1000

Vo

lum

e f

racti

on

[%

]

Crystal size [microns]

100rpm150rpm200rpm250rpm

Solubility, Nucleation & Growth Kinetics Data

Library of CFD Database for Design & Scale-up of Crystallisation Processes

SOP’s to Estimate Key Kinetics Parameters Using gCRYSTAL Parameters Estimation Tool

Scale-up Correlations

Strategy Define “Well Mixed” Zones

Developed CFD Methodology

Page 5: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Interactions Between CFD and gCRYSTAL5

BACG 2017

1.1. Coupling with single well-mixed zone system

CFD Fluent

Hydrodynamics/mixing/

heat transfer

1.2. Coupling with Multi-zonal model

Network of Well-mixed Zones

Zonal process

Model

gCRYSTAL

gCRYSTAL

Single well mixed

zone

CFD Fluent

Hydrodynamics/mixing/

heat transfer

Inter-zone mass flow rates

Lumped hydrodynamics parameters

• Impeller power number• Impeller pumping number• Pumping efficiency• Secondary circulation flow

• Mass & momentum balances (velocities, solute concentration & Temperature distribution)

• Identify well mixed zones • Coordinates centre each zone

Page 6: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Development & Validation of CFD Methodology: Single Phase

6

27/07/2017

CBBII project: 20 L single Beavertail baffle reactor with a retreat curve impeller

BACG 2017

______________________[1] Li, M., Graeme White, G., Wilkinson, D., Roberts, K.J., 2004. LDA measurements and CFD modelling of a stirred vessel with a Retreat curve impeller, Ind. Eng. Chem. Res., 43, 6534-6547

Mesh: Tetrahedrons, Cells 597.801, Nodes

133.153

CFD analysis for different turbulence models including: Shear Stress Transport (SST) & Reynold Stress Transport (RST) both for flat & free surface (coupled with Volume of Fluid (VOF) model). RST including Scalable Wall Functions (SWF)

Obtain prediction of velocity components as

well as capture vortex profile

Different impeller speeds: 100, 150, 200

&250 rpm

Page 7: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Development & Validation of CFD Methodology: Velocity Components at 100 rpm

7

27/07/2017 BACG 2017LDA RST SWFRST SWF VOF

RST: Reynold stress transport SWF: Scalable wall functions VOF: Volume of fluid model

-0.3

-0.2

-0.1

0

0.1

0.2

0.3

0.08 0.1 0.12 0.14

Axi

al v

elo

city

(m

/s)

Radial position -0.35

-0.25

-0.15

-0.05

0.05

0.15

0.25

0.35

0.08 0.1 0.12 0.14

Rad

ial v

elo

city

(m

/s)

Radial position -0.6

-0.4

-0.2

0

0.2

0.4

0.6

0.08 0.1 0.12 0.14

Tan

gen

tial

ve

loci

ty (

m/s

)

Radial position

-0.3

-0.2

-0.1

0

0.1

0.2

0.3

0 0.05 0.1 0.15

Axi

al v

elo

city

(m

/s)

Radial position -0.35

-0.25

-0.15

-0.05

0.05

0.15

0.25

0.35

0 0.05 0.1 0.15

Rad

ial v

elo

city

(m

/s)

Radial position-0.6

-0.4

-0.2

0

0.2

0.4

0.6

0 0.05 0.1 0.15

Tan

gen

tial

ve

loci

ty (

m/s

)

Radial position

-0.3

-0.2

-0.1

0

0.1

0.2

0.3

0 0.05 0.1 0.15

Axi

al v

elo

city

(m

/s)

Radial position-0.35

-0.25

-0.15

-0.05

0.05

0.15

0.25

0.35

0 0.05 0.1 0.15

Rad

ial v

elo

city

(m/s

)

Radial position-0.6

-0.4

-0.2

0

0.2

0.4

0.6

0 0.05 0.1 0.15

Ta

nge

nti

al v

elo

city

(m

/s)

Radial position

Page 8: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Development & Validation of CFD Methodology: Vortex Profile

8

27/07/2017 BACG 2017

90 deg plane_100, 150,200 & 250 rpm

Single baffle does not

suppress vortex

Volume of Fluid (VOF)

model needed to assess

hydrodynamics

Effect of impeller speed

& viscosity on vortex

depth

90 deg plane_ 150 rpm, vis_0.001_0.0037, 0.0108, 0.0601

Transitional

SST VOF

Water turbulent Turbulent Laminar

Water/glycerine

Page 9: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Development & Validation of CFD Methodology: Hydrodynamic Macro-parameters

9

27/07/2017 BACG 2017

𝒘𝒅 = න𝒛𝒃

𝒛𝒕

𝟐𝝅𝝆𝑹𝒃𝒗𝒓𝒅𝒛

Pumping capacity (discharge flow)

𝑵𝒅 =𝒘𝒅

𝝆𝑵𝑫𝟑

Pumping efficiency: Pumping capability per unit of power consumed

𝜼 =𝑵𝒅

𝑵𝒑

Secondary circulationflow

𝑵𝒄 =𝒘𝒖𝒑

𝝆𝑵𝑫𝟑𝒘𝒖𝒑 = න𝑨+

𝝆𝒗𝒛𝒅𝑨𝒛

0.50

0.70

0.90

1.10

1.30

1.50

0.E+00 2.E+04 4.E+04 6.E+04 8.E+04 1.E+05 1.E+05 1.E+05 2.E+05

Np

Re Water water_glycerol

Power number

𝑵𝒑 =𝑷

𝝆𝑵𝟑𝑫𝟓𝑷 = 𝝎න

𝑨

𝒓(𝝉𝒅𝑨)

0.20

0.25

0.30

0.35

0.40

0.45

0.50

0.E+00 2.E+04 4.E+04 6.E+04 8.E+04 1.E+05 1.E+05 1.E+05 2.E+05

Nd

Re Water Water_glycerol

0.20

0.25

0.30

0.35

0.40

0.45

0.50

0.E+00 2.E+04 4.E+04 6.E+04 8.E+04 1.E+05 1.E+05 1.E+05 2.E+05

Nc

ReWater Water_glycerol

Page 10: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Cooling Crystallisation of L-Glutamic Acid (LGA) α-form in Aqueous Solution: Measuring Crystal Size Distribution (CSD)

10

27/07/2017 ADDOPT LEEDS W.P.4.3

Chiller

USS

Flow-through Cell

Mono Pump

JacketedTubes

Glass Tank

Reactor

Turbidity

Probe

PT100

Baffle

Cooling

Coils

Frame

Temperature

Control PC

USS PC

B

C

E

F

G

I H A

D

0

1

2

3

4

5

6

7

8

9

0.1 1 10 100 1000

Vo

lum

e f

racti

on

[%

]

Crystal size [microns]

100rpm 150rpm

200rpm 250rpm

On-line ultrasonic spectrometer

______________________2. K. Liang, Process Scale Dependence of L-glutamic Acid Batch Crystallised from Aqueous Solution in relation to Reactor Internals, Reactant Mixing and Process Conditions, Department of Chemical Engineering, Heriot-Watt University, Edinburgh, 2002.

100microns

Microscopic images of α-form L-glutamic acid

crystals obtained at the end of batch cooling

crystallisation from aqueous solution at 200rpm

Experimental conditions:

Solution

concentration:

45g/100g

Cooling rate: 0.6

deg/min

Stirrer speed: 100,

150, 200 & 250 rpm

Page 11: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

27/07/2017 BACG 2017

11

Modelling Methodology: Multiphase CFD Coupled with Population Balance Model (PBM)

𝟏

𝝆𝒓𝒒

𝝏

𝝏𝒕𝜶𝒒𝝆𝒒 + 𝜵. 𝜶𝒒𝝆𝒒𝒗𝒒 =

𝒑=𝟏

𝒏

ሶ𝒎𝒑𝒒 − ሶ𝒎𝒒𝒑Continuity

𝝏

𝝏𝒕𝜶𝒔𝝆𝒔𝒗𝒔 + 𝜵. 𝜶𝒔𝝆𝒔𝒗𝒔 𝒗𝒔

= −𝜶𝒔𝜵𝒑 − 𝜵𝒑𝒔 + 𝜵. ധ𝝉𝒒 + 𝜶𝒔𝝆𝒔𝒈 +

𝒑=𝟏

𝑵

𝑲𝒍𝒔 𝒗𝒍 − 𝒗𝒔 + ሶ𝒎𝒍𝒔𝒗𝒍𝒔 − ሶ𝒎𝒔𝒍𝒗𝒔𝒍 + 𝑭𝒔 + 𝑭𝒍𝒊𝒇𝒕,𝒔 + 𝑭𝒗𝒎,𝒔 + 𝑭𝒕𝒅,𝒔

Fluid-Solid momentum

𝑲𝒔𝒍 =𝜶𝒔𝝆𝒔𝒇

𝝉𝒔𝝉𝒔 =

𝝆𝒔𝒅𝒔𝟐

𝟏𝟖𝝁𝒍

𝝏

𝝏𝒕𝝆𝒒𝜶𝒒𝒀𝒊

𝒒+ 𝜵. 𝝆𝒒𝜶𝒒𝒗𝒒𝒀𝒊

𝒒= −𝜵.𝜶𝒒Ԧ𝑱𝒊

𝒒+ 𝜶𝒒𝑹𝒊

𝒒+ 𝜶𝒒𝑺𝒊

𝒒+

𝒑=𝟏

𝒏

ሶ𝒎𝒑𝒊𝒒𝒋 − ሶ𝒎𝒒𝒋𝒑𝒊 +𝓡Species transport

𝝏

𝝏𝒕𝝆𝜶𝒇𝒊 + 𝜵. 𝒖𝒑𝜶𝒇𝒊 = 𝑺𝒃𝒊

Transport equation for the discrete bin fraction 𝒇𝒊

𝑓𝑖 =𝛼𝑖𝛼

𝒅𝒔 =σ𝑵𝒊𝑳𝒊

𝟑

σ𝑵𝒊𝑳𝒊𝟐

𝝏

𝝏𝒕𝝆𝒔𝜶𝒊 + 𝜵. 𝝆𝒔𝒖𝒊𝜶𝒊 +

𝝏

𝝏𝑽

𝑮𝒗𝝆𝒔𝜶𝒊𝑽

= 𝝆𝒔𝑽𝒊 𝑩𝒂𝒈,𝒊 − 𝑫𝒂𝒈,𝒊 + 𝑩𝒃𝒓,𝒊 − 𝑫𝒃,𝒊 +𝑶𝒊𝝆𝒔𝑽𝟎 ሶ𝒏𝟎PBM

Page 12: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Population Balance Model for Cooling Crystallisation of LGA in Aqueous Solution

27/07/2017 BACG 2017

12

One-dimensional (1D) population balance model for a well mixed reactor. Disregarding agglomeration &

breakage

𝝏

𝝏𝒕𝝆𝒔𝜶𝒊 + 𝜵. 𝝆𝒔𝒖𝒊𝜶𝒊 +

𝝏

𝝏𝑽

𝑮𝒗𝝆𝒔𝜶𝒊𝑽

= 𝝆𝒔𝑽𝒊 𝑩𝒂𝒈,𝒊 − 𝑫𝒂𝒈,𝒊 + 𝑩𝒃𝒓,𝒊 − 𝑫𝒃,𝒊 + 𝝆𝒔𝑽𝟎 ሶ𝒏𝟎

𝝏

𝝏𝒕𝝆𝒔𝜶𝒊 + 𝜵. 𝝆𝒔𝒖𝒊𝜶𝒊 +

𝝏

𝝏𝑽

𝑮𝒗𝝆𝒔𝜶𝒊𝑽

= 𝝆𝒔𝑽𝟎 ሶ𝒏𝟎

𝑮 = 𝒌𝑮 𝝈 𝒏 𝑱 = 𝒌𝑩 𝝈 𝒃

𝒌𝑮 = 𝟗. 𝟕𝟔 𝒙 𝟏𝟎−𝟎𝟖

𝒏 = 𝟐. 𝟑𝟒 𝒃 = 𝟏. 𝟖𝟕

𝒌𝑱 = 𝟒. 𝟎𝟐 𝒙 𝟏𝟎 𝟔

[3] Y. Clifford, W.L. Shei, 1992. Crystallisation kinetics and product purity of alpha-glutamic acid crystal, Chem. Eng. Comm., 120, 139-152

Page 13: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

27/07/2017 BACG 2017

13

Contours for Cooling Crystallisation of LGA in Aqueous Solution: Cooling from 70 to 25 deg C at 100 rpm

Temperature distribution Mass fraction of LGA

Volume fraction of liquid phase

Volume fraction of solid phase Velocity vectors

95.24, 1.88

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

1.8

2.0

20 200 2000V

olu

me f

racti

on

[%

]

Crystal size [microns]

Exp. centre at 200

Page 14: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Influence of Hydrodynamics on Nucleation Kinetics & CSD of L-GA Aqueous: Solutions 450 ml reactor/Nyvlt Approach

14

0

1

2

3

4

5

6

7

8

9

0.1 1 10 100 1000

Vo

lum

e f

racti

on

[%

]

Crystal size [microns]

500

400

300

200

0.5

1

1.5

2

2.5

3

3.5

100 200 300 400 500 600

Nu

cle

ati

on

ord

er(

mo

)

Stirrer speed [rpm]

0

0.0005

0.001

0.0015

0.002

0.0025

100 200 300 400 500 600

Nu

cle

ati

on

ra

te c

on

sta

nt

(Kj)

Stirrer speed [rpm]

3

4

5

6

7

8

9

10

11

0

5

10

15

20

25

30

35

40

45

50

0 200 400 600 800 1000

MS

ZW

(°C

)

Stirrer speed [rpm]

0.2 C/min

0.3 C/min

0.5 C/min

Mullin

[2] K. Liang, Process Scale Dependence of L-glutamic Acid Batch Crystallised from Aqueous Solution in relation to Reactor Internals, Reactant Mixing andProcess Conditions, Department of Chemical Engineering, Heriot-Watt University, Edinburgh, 2002.

𝑱 = 𝒌𝒋 ∆𝑪𝒎𝒂𝒙𝒎𝟎

Page 15: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Scale-up Model for Batch Cooling Crystallisation of LGA Aqueous Solutions : Cooling Rate 0.2 ⸰C/min

15

10

100

1.E+03 1.E+04 1.E+05 1.E+06

MS

ZW

[°C

]

Re [-]

450ml 2-litre 20-litre

10

20

30

40

0 5 10 15

MS

ZW

[°C

]

Re [104]

450ml 2-litre 20-litre

15

20

25

30

35

40

0 100 200 300 400

Me

tas

tab

le z

on

e w

idth

[°C

]

Stirrer speed [rpm]

20-litre 2-litre 450ml

∆𝒕𝒄= −𝟎. 𝟎𝟓𝑵 + 𝟑𝟓.𝟏

y = 18.95xR2 = 0.94

0.15

0.20

0.25

0.30

0.35

0.005 0.010 0.015 0.020(

t c/t

e)1

.54 [-]

Re-0.5 T/T0 [-]∆𝒕𝒄𝒕𝒆

𝟏.𝟓𝟒

= 𝟏𝟖. 𝟗𝟓𝑹𝒆−𝟎.𝟓

𝑻

𝑻𝒐t is temperature

T is reactor diameter

To laboratory reactor diameter

𝑱 ∝∆𝒕𝒄𝒕𝒆

𝒎

= 𝒂 𝑹𝒆𝒃

𝑻

𝑻𝒐

[4] K. Liang, G White, D Wilkinson, L J Ford, K J Roberts, W M L Wood, 2004. Examination of the process scale dependence of L-glutamic acid batch crystallised from supersaturated aqueous solution in relation to reactor hydrodynamics, Ind. Eng. Chem. Res., 43, 1227-1234

Page 16: Modelling pharmaceutical crystallisation processes using …€¦ · Modelling pharmaceutical crystallisation processes using a coupled CFD-population ... Model gCRYSTAL CFD Fluent

Concluding Remarks and Future work 16

27/07/2017 BACG 2017

CFD methodology developed for improved predictions of velocity components Assessment of 20 L reactor hydrodynamics as a function of impeller speed,

viscosity & density

Ongoing work: modelling batch cooling crystallisation of LGA in 20 L reactor: CFD & 1D-PBM for different impeller speeds (100, 150, 200 &250 rpm). Power laws for nucleation & growth kinetics are used within 1D-PBM incorporated through user defined function (UDFs)

Short term future work will include:

1. Assessment of first principles primary/secondary nucleation & growth kinetic models that can be used with 1D-PBM for improved predictions of CSD

2. Application of the developed CFD & 1D-PBM methodology to model batch cooling crystallisation, for a selected solution system, for laboratory & pilot scale reactors

Development of scale-up correlationsIncorporation of models through UDFs